Rabbit Polyclonal WNT7A antibody. Suitable for WB, ICC/IF and reacts with Human, Mouse samples. Cited in 21 publications.
pH: 7.4
Preservative: 0.02% Sodium azide
Constituents: 98.98% PBS, 1% BSA
WB | ICC/IF | |
---|---|---|
Human | Tested | Expected |
Mouse | Tested | Expected |
Chicken | Predicted | Predicted |
Chimpanzee | Predicted | Predicted |
Gorilla | Predicted | Predicted |
Orangutan | Predicted | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1 µg/mL | Notes Abcam recommends using 5% BSA as the blocking agent. |
Species Mouse | Dilution info 1 µg/mL | Notes Abcam recommends using 5% BSA as the blocking agent. |
Species | Dilution info | Notes |
---|---|---|
Species Chicken, Chimpanzee, Gorilla, Orangutan | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 5 µg/mL | Notes - |
Species Mouse | Dilution info 5 µg/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Chicken, Chimpanzee, Gorilla, Orangutan | Dilution info - | Notes - |
Select an associated product type
Ligand for members of the frizzled family of seven transmembrane receptors that functions in the canonical Wnt/beta-catenin signaling pathway (By similarity). Plays an important role in embryonic development, including dorsal versus ventral patterning during limb development, skeleton development and urogenital tract development (PubMed:16826533). Required for central nervous system (CNS) angiogenesis and blood-brain barrier regulation (PubMed:30026314). Required for normal, sexually dimorphic development of the Mullerian ducts, and for normal fertility in both sexes (By similarity). Required for normal neural stem cell proliferation in the hippocampus dentate gyrus (By similarity). Required for normal progress through the cell cycle in neural progenitor cells, for self-renewal of neural stem cells, and for normal neuronal differentiation and maturation (By similarity). Promotes formation of synapses via its interaction with FZD5 (By similarity).
Protein Wnt-7a, WNT7A
Rabbit Polyclonal WNT7A antibody. Suitable for WB, ICC/IF and reacts with Human, Mouse samples. Cited in 21 publications.
pH: 7.4
Preservative: 0.02% Sodium azide
Constituents: 98.98% PBS, 1% BSA
From Mar 2024, QC testing of replenishment batches of this polyclonal changed. All tested and expected application and reactive species combinations are still covered by our Abcam product promise. However, we no longer test all applications. For more information on a specific batch, please contact our Scientific Support who will be happy to help.
Abcam is leading the way to address reproducibility in scientific research with our highly validated recombinant monoclonal and recombinant multiclonal antibodies. Search & select one of Abcam's thousands of recombinant alternatives to eliminate batch-variability and unnecessary animal use.
If you do not find a host species to meet your needs, our catalogue and custom Chimeric range provides scientists the specificity of Abcam's RabMAbs in the species backbone of your choice. Remember to also review our range of edited cell lines, proteins and biochemicals relevant to your target that may help you further your research goals.
Abcam antibodies are extensively validated in a wide range of species and applications, so please check the reagent specifications meet your scientific needs before purchasing. If you have any questions or bespoke requirements, simply visit the Contact Us page to send us an inquiry or contact our Support Team ahead of purchase.
Wnt7a also known as Wingless-type MMTV integration site family member 7A is a protein involved in various cellular processes. It has a molecular mass of approximately 39 kDa and is expressed in several tissues including the brain lungs and kidneys. Mechanically Wnt7a acts as a signaling molecule that binds to frizzled receptors on cell surfaces initiating downstream signaling cascades that result in the transcriptional regulation of target genes.
This protein plays a critical role in the regulation of developmental processes including cell proliferation differentiation and migration. Wnt7a is part of the Wnt signaling pathway which is a complex network of proteins known for its involvement in embryonic development and regulation of cell fate decisions. The pathway contributes to the proper formation of tissues and organs and maintains cellular homeostasis.
Wnt7a is significantly involved in the canonical Wnt/β-catenin signaling pathway as well as the planar cell polarity pathway. In the canonical pathway Wnt7a influences the stabilization and translocation of β-catenin to the nucleus promoting transcription of target genes. It also interacts with other Wnt proteins like Wnt3a and different frizzled receptors playing roles in various cell signaling events and modulating cellular communication.
Wnt7a is linked to limb malformation disorders such as Fuhrmann syndrome and Al-Awadi/Raas-Rothschild/Schinzel phocomelia syndrome. These conditions arise from mutations that affect the function of Wnt7a disrupting normal limb development. Additionally aberrant Wnt7a signaling has implications in cancer particularly in the modulation of tumor microenvironment and metastasis where altered interactions with proteins like β-catenin can contribute to oncogenic processes.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Exposure: 4 minutes
Blocking buffer: 2% BSA
Gel type: MOPS
Observed band size: 41 kDa
Additional bands: 50 kDa, 27kDa
All lanes: Western blot - Anti-Wnt7a antibody (ab100792) at 1 µg/mL
Lane 1: Human Kidney lysate at 10 µg
Lane 2: Mouse Kidney lysate at 10 µg
Lane 3: HepG2 whole cell lysate at 10 µg
Lane 4: COLO 205 whole cell lysate at 10 µg
Lane 5: Human Colon tumour tissue lysate at 10 µg
All lanes: Goat Anti-Rabbit IgG H&L (HRP) at 1/50000 dilution
Predicted band size: 39 kDa
All lanes: Western blot - Anti-Wnt7a antibody (ab100792) at 1 µg/mL
All lanes: Human kidney tissue lysate - total protein (ab30203) at 10 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (Goat Anti-Rabbit IgG H&L (HRP) preadsorbed ab97080) at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 39 kDa
Observed band size: 15 kDa, 28 kDa, 41 kDa
Exposure time: 16min
ab100792 staining Wnt7a in HepG2 cells. The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% PBS-Tween for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated overnight at 4°C with ab100792 at 1µg/ml and Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291, Mouse monoclonal [DM1A] to alpha Tubulin - Loading Control. Cells were then incubated with Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081, Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 488), pre-adsorbed at 1/1000 dilution (shown in green) and Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) preadsorbed ab150120, Goat polyclonal Secondary Antibody to Mouse IgG - H&L (Alexa Fluor® 594), pre-adsorbed at 1/1000 dilution (shown in pseudocolour red). Nuclear DNA was labelled with DAPI (shown in blue).
Also suitable in cells fixed with 4% paraformaldehyde (10 min).
Image was acquired with a high-content analyser (Operetta CLS, Perkin Elmer) and a maximum intensity projection of confocal sections is shown.
Image collected and cropped by CiteAb under a CC-BY license from the publication
Wnt7a western blot using anti-Wnt7a antibody ab100792. Publication image and figure legend from Ma, A. Y., Xie, S. W., et al., 2017, Int J Mol Sci, PubMed 28640224.
ab100792 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab100792 please see the product overview.
The effects of NOMAC on the protein levels of SUFU and Wnt7a in cultured cells (RL95-2 and KLE), as assessed by Western blot. The relative amounts of SUFU and Wnt7a, collected from NOMAC-treated RL95-2 and KLE cells, were determined by Western blot for the indicated times. GAPDH was used as a loading control. Cells were cultured with DMSO (control) or graded concentrations of NOMAC (4, 20, and 100 μmol/L) for 6, 24, and 48 h. All of the results came from three independent experiments. The data were expressed as mean ± SD. (A) The protein expression of SUFU and Wnt7a in response to NOMAC treatment in RL95-2 cells; (B) NOMAC did not alter the expression levels of SUFU and Wnt7a as assessed by Western blot analysis in KLE Cells. * p < 0.05, ** p < 0.01 relative to the control group.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com